Steven Cohen's position in Crinetics Pharmaceuticals is currently worth $85.6 Million. That's 0.26% of their equity portfolio (104th largest holding). The investor owns 2.98% of the outstanding Crinetics Pharmaceuticals stock. The first Crinetics Pharmaceuticals trade was made in Q3 2019. Since then Steven Cohen bought shares eleven more times and sold shares on ten occasions. The stake costed the investor $77.8 Million, netting the investor a gain of 9.9% so far.